Decoding Hormones: A Modern Look at Women’s Health, Cancer Risk, and Chronic Pain
Abstract
As a practitioner dedicated to integrative health, I frequently encounter patients searching for answers that conventional medicine hasn’t provided. This educational post aims to demystify the complex world of hormones—specifically estrogen, progesterone, and testosterone—and their profound impact on women’s health, from menopause and chronic pain to cancer risk and overall vitality. We will journey through the history of hormone research, dissecting the pivotal Women’s Health Initiative (WHI) study and its long-term consequences, and challenge long-held myths with compelling, evidence-based research from leading figures in the field. By exploring the molecular differences between bioidentical hormones and synthetic progestins, we can understand why hormone type and delivery systems are crucial for safety and efficacy. Crucially, this discussion will explore how an integrative chiropractic approach, focusing on the body’s structural and neurological integrity, provides a foundational pillar for achieving hormonal balance and overall wellness. My goal is to empower you with knowledge, helping you make informed decisions about your health journey by combining an evidence-based understanding of hormone biochemistry with a foundational chiropractic approach that honors the body’s innate intelligence.
Rethinking the Women’s Health Initiative: What If We Got It Wrong?
As a clinician, I often begin my consultations by asking, “Why are you here today?” The answer, more often than not, is a quiet frustration. Many of my patients feel that the conventional approaches they’ve tried simply aren’t working. They don’t feel better, they’re not content, and they’re searching for a different path. This is where our journey of discovery begins—by asking “why” and challenging long-held assumptions.
Let’s start with a significant moment in medical history: the Women’s Health Initiative (WHI) study. This study, published in 2002, dramatically changed the landscape of hormone therapy. But I often wonder, what if the study had been designed differently? What if, instead of using conjugated equine estrogens (like Premarin) and a synthetic progestin (medroxyprogesterone acetate, found in Prempro), the researchers had used bioidentical hormones?
Imagine if they had used a 17-beta estradiol patch, a form of estrogen identical to what the human body produces, delivered non-orally. This is a critical distinction.
Oral vs. Non-Oral Delivery: When you take a hormone pill, it first passes through your digestive system and then to your liver—a process known as the first-pass metabolism. Your liver has to work extra hard to process this substance. In response, it produces various byproducts, including an increased amount of clotting factors. This is why oral contraceptives and oral estrogen therapies like Premarin are known to increase the risk of blood clots.
The Cardioprotective Effect: We’ve long known that estrogen has cardioprotective benefits. However, when you take it in pill form, which slightly increases clotting, you effectively negate that heart-protective benefit. Most heart attacks and strokes are, at their core, related to clotting events. So, the WHI concluded that hormones didn’t help, but in reality, it may have been the wrong molecule delivered through the wrong system.
Had the WHI used bioidentical estradiol delivered via a patch or cream, which bypasses that first-pass liver metabolism, and paired it with natural, bioidentical progesterone, I firmly believe we would not be having this conversation today. The medical establishment would likely recommend that every woman begin estrogen and progesterone therapy at the onset of menopause and continue it for life. The science would have been clear.
The Aftermath of 2002: A Public Health Crisis
I was in private practice in 2002 when the results of the WHI study hit the front page of Time magazine with the headline, “The Truth About Hormones.” Positive news rarely makes the front page; fear sells. And this news scared millions. I had to hire an extra receptionist just to handle the flood of calls from panicked women wanting to stop their hormone therapy immediately.
In the years that followed, an estimated half a million women in the U.S. stopped their hormone therapy. What have we seen since then?
Cognitive Decline: How are we doing with Alzheimer’s disease and cognitive decline in women? The rates are staggering. I see the heartbreaking effects in my community, where women who were once vibrant and sharp now struggle with basic memory and function.
Heart Disease: Have we made any significant progress in reducing heart disease deaths over the last 25 years? The statistics show little improvement. We stopped using one of the most cardioprotective substances available to women.
Bone Health: Hip fractures, often a devastating event for older adults, are intrinsically linked to the loss of bone density that accelerates after menopause when estrogen levels plummet.
From a musculoskeletal and neurological perspective, the loss of estrogen is catastrophic. As a chiropractor, I focus on the intricate connection between the nervous system, spine, and overall body function. Hormones, particularly estrogen, are powerful neurological modulators. They influence pain perception, inflammation, and tissue repair. When these hormone levels decline, patients often experience a surge in chronic pain, joint stiffness, and a decreased ability to heal from injuries. This is why a purely mechanical approach to back pain or joint issues in menopausal women often falls short. We must consider the underlying biochemical environment.
Vindicating Estrogen: The Long-Term Data
The story doesn’t end in 2002. Researchers continued to follow the same group of women from the WHI study. What they found, years later, completely upended the initial conclusions.
A follow-up report published in 2013, after a median of 18 years, found that estrogen-alone therapy (the Premarin-only arm) was not associated with an increased risk of all-cause, cardiovascular, or cancer mortality. It was a quiet retraction, a “never mind” that didn’t make front-page news. It was an apology to the grandmothers who suffered from preventable fractures and the grandfathers who faded away with Alzheimer’s.
It gets even more compelling. In 2020, another analysis of the same long-term data was published in JAMA. This analysis found that women who took estrogen-only for approximately eight years had a lower incidence of breast cancer and were less likely to die from it over the course of their lives.
Let that sink in. The only medicine in the history of medical science that has been shown in a prospective, randomized, placebo-controlled trial to reduce a woman’s chance of both getting and dying from breast cancer is estrogen. And this was demonstrated with Premarin, a formulation derived from horse urine that is far from ideal. Imagine the potential benefits of using bioidentical estradiol. This evidence, which came out years ago, should have revolutionized how we approach women’s health. We should be ensuring our patients are well-informed to help prevent breast cancer, not withholding it out of fear.
The Progesterone vs. Progestin Debate: Getting the Molecules Right
It is absolutely critical to understand the difference between progesterone and progestins. They are not the same. When I see a new study claiming “hormone replacement therapy” caused a negative outcome, the first thing I do is check the abstract to see which molecules were used. If they used a synthetic progestin, I know the results are likely skewed.
Progesterone (P4): This is the natural hormone our bodies produce. It has a specific molecular structure that fits perfectly into our progesterone receptors. It is neuroprotective and has calming effects, which is why it’s so beneficial for sleep.
Progestins: These are synthetically created molecules designed to mimic some of progesterone’s effects. There are many different families, such as medroxyprogesterone acetate and norethindrone acetate. Their structures differ from those of natural progesterone, and they can bind to other hormone receptors (such as androgen or glucocorticoid receptors), leading to a range of side effects. The WHI study used a synthetic progestin, not bioidentical progesterone, and this was the source of the trend towards increased breast cancer risk.
The constant confusion in the media and even in some medical literature between these two distinct classes of substances is a major source of misinformation. When I refer to progesterone, I am exclusively talking about bioidentical, natural progesterone.
The Chiropractic Connection: Structural Integrity and Hormonal Flow
From an integrative chiropractic standpoint, we see the body as a self-regulating, self-healing organism. Our primary goal is to remove interference to the nervous system, which controls and coordinates every other system in the body, including the endocrine (hormone) system. Misalignments in the spine, known as vertebral subluxations, can create nerve interference that disrupts the delicate communication pathways between the brain and the glands that produce hormones, like the ovaries.
We utilize specific chiropractic adjustments to restore proper spinal alignment and motion. This isn’t just about relieving back pain; it’s about optimizing nerve function. By ensuring the nerves that supply the pelvic organs are free from interference, we help create an optimal physiological environment for the endocrine system to function. Physical therapy modalities are also integrated to strengthen core muscles, improve posture, and support the structural integrity that is foundational to neurological health. When a woman is going through menopause, her body is already under significant stress. Adding the stress of nerve interference from a misaligned spine can exacerbate symptoms like hot flashes, mood swings, and sleep disturbances. By addressing the structural component, we support the body’s innate ability to adapt and find balance.
Testosterone: The Underappreciated Hormone for Women’s Health
One of the most persistent and damaging myths in medicine is that testosterone is a “male hormone.” This is fundamentally incorrect. In fact, over her lifetime, a woman produces significantly more testosterone than she does estrogen. The highest production occurs in the first 30-35 years of life, which is why its decline is so acutely felt as women enter perimenopause and menopause. Further proof lies in our genetics: the androgen receptor is located on the X chromosome. You can’t obtain more evidence than that to show it is essential for both sexes.
A fascinating study revealed that removing the ovaries in menopausal women (oophorectomy) led to a significant increase in the risk of all-cause mortality, heart disease, and strokes. However, women who retained their ovaries, even post-menopause, had substantially lower risks. The question is, what is that tiny menopausal ovary producing that offers such protection? The answer is testosterone. That small amount was the critical factor, influencing everything from cardiovascular function to longevity.
Testosterone: A Protective Force Against Breast Cancer
This brings us to one of the most exciting and underappreciated areas of research: the protective role of testosterone in women, especially concerning breast cancer. The leading voice in this field is Dr. Rebecca Glaser, a breast surgeon whose work has demonstrated time and again that testosterone is not the enemy; it is a powerful ally.
Here’s what the evidence shows:
Testosterone is Anti-Proliferative: In study after study, testosterone has been shown to have anti-inflammatory and anti-cancer effects on breast tissue.
Improving Quality of Life During Cancer Treatment: Many women on aromatase inhibitors suffer debilitating side effects like joint pain and fatigue. Dr. Glaser’s research showed that giving these women testosterone dramatically improved their quality of life, helping them adhere to their life-saving treatment.
Direct Anti-Tumor Effects: In a remarkable study, Dr. Glaser’s team implanted testosterone pellets directly into the tissue surrounding breast tumors before surgery. They observed a staggering 46% average reduction in tumor volume, providing powerful evidence of testosterone’s anti-cancer properties.
A landmark prospective study she conducted followed more than 1,000 women for 5 years. The study predicted 80 invasive breast cancers would occur in this group based on standard risk models. In the women receiving testosterone therapy, only 11 occurred. This represents a massive reduction in breast cancer incidence, demonstrating a powerful protective effect.
Hormones and Chronic Pain: The Missing Piece in Pain Management
As a specialist in musculoskeletal and spinal health, I work extensively with patients suffering from chronic pain. The literature is rich in data linking testosterone, thyroid hormones, and progesterone to pain perception, yet this knowledge often remains siloed.
The Opioid-Hormone Vicious Cycle: Chronic pain patients are often on opioids. Increased pain leads to higher opioid doses, which in turn suppress critical hormones like testosterone. Low testosterone then exacerbates pain perception, creating a feedback loop.
A Call for a New Standard of Care: Leading voices in pain management now argue that functional testosterone testing and replacement should be a mandatory component of care for chronic pain patients.
I vividly recall a patient with a fibromyalgia diagnosis. She had suffered for years with widespread pain and fatigue. After a comprehensive evaluation that included her hormonal status, we began a protocol to optimize her testosterone levels alongside targeted chiropractic care and physical therapy. Within months, her change was remarkable. She told me, “You know what, my fibromyalgia is gone.” Her experience, and many others since, has solidified my conviction.
The mechanism is fascinating. The conversion of testosterone to estrogen is crucial for joint health. Estrogen helps maintain joint integrity. The number one symptom of menopause is not hot flashes, but joint pain, bone pain, and muscle pain. It’s the first sign of what I call “Energy Deficiency Syndrome,” a state in which the body’s hormonal engine is running on empty.
The Role of Integrative Chiropractic in Pain and Hormonal Balance
The connection between my work at a chiropractic clinic and hormonal health is direct and synergistic.
Addressing the Root of Musculoskeletal Pain: When a patient presents with chronic joint pain or fibromyalgia, simply adjusting the spine or prescribing exercises may only provide temporary relief if the underlying issue is hormonal. By integrating a functional medicine assessment, we can address the biochemical root of their pain. Optimizing testosterone not only reduces inflammation but also enhances joint health from within.
Enhancing Physical Therapy Outcomes: Patients with low testosterone suffer from fatigue, low motivation, and an inability to build muscle (sarcopenia). This makes it incredibly difficult to benefit from physical therapy. Restoring their hormonal balance gives them the energy, strength, and drive to perform their prescribed exercises, leading to faster recovery. Chiropractic adjustments become more effective as the supporting musculature strengthens, allowing adjustments to be held longer and improving overall biomechanics.
A Whole-Body Approach: My philosophy, as both a Doctor of Chiropractic (DC) and an Advanced Practice Registered Nurse Practitioner (APRN), is to view the body as an interconnected system. The nervous system, which I directly influence through chiropractic care, is intricately linked with the endocrine (hormone) system. Stress on the spine can impact hormonal regulation, and hormonal imbalances can increase pain sensitivity. By addressing both simultaneously—optimizing spinal function through adjustments and cellular function through hormonal balance—we create a powerful healing synergy that leads to true, lasting health.
By combining an evidence-based understanding of hormone biochemistry with a foundational chiropractic approach that honors the body’s structural and neurological integrity, we can create a truly holistic and effective path to wellness for women at every stage of life.
Estrogen, Whole-Body Physiology, and Evidence-Based Clinically Integrated Care
Abstract:
In this educational post, I present a comprehensive, evidence-informed perspective on sex hormones—emphasizing estrogen’s multi-system roles—and how modern chiropractic, physical therapy, and integrative rehabilitation strategies support whole-person outcomes. Drawing on leading research and my clinical observations, I unpack persistent myths around estrogen and disease risk, clarify receptor pharmacology, and explain why individualized optimization benefits bone integrity, neuroprotection, cardiovascular resilience, and pain modulation. I prioritize musculoskeletal, neurological, and metabolic care pathways: spinal biomechanics, neurodynamic mobilization, neuromuscular re-education, fascial health, and graded, outcome-driven functional rehabilitation.
Evidence-Based Estrogen Physiology, Spine Health, and Functional Rehabilitation: An Integrated Care Guide by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST
Setting the Stage: From Symptom Suppression to Systems Integration
I have spent years helping patients move away from an allopathic mindset that equates care with symptom suppression. The better question is not “What can we prescribe to stop a symptom?” but “What physiological process is dysregulated, and how do we restore homeostasis?” In spine and musculoskeletal care, the same principle holds: rather than masking low back pain with short-term fixes, we assess alignment, tissue load, sensory-motor control, inflammatory balance, and lifestyle drivers. This is where the modern evidence on sex hormones—kept in perspective—interfaces with chiropractic and physical therapy: hormones modulate tissue turnover, neural plasticity, pain processing, and endothelial health. That means targeted manual therapy, corrective exercise, gait retraining, and neurodynamic techniques often work better and last longer when the underlying physiology is supported.
Key mindset shifts I encourage:
Focus on root-cause, systems-based thinking
Use individualized, evidence-guided plans over one-size-fits-all protocols
Blend manual therapy, functional exercise, and lifestyle medicine with measured medical input when necessary
Estrogen Is Not Just About Hot Flashes: Whole-System Physiology
The misconception that estrogen is simply about vasomotor symptoms ignores the breadth of its actions. Estrogen receptors (ERα and ERβ) are distributed across bone, brain, heart, gut, immune cells, and connective tissue. In clinical musculoskeletal care, that matters because estrogen influences:
Bone remodeling and osteoblast/osteoclast signaling
Synaptic plasticity and descending pain modulation
Microglial and astrocyte activation states after CNS injury
Endothelial nitric oxide signaling and vascular health
Collagen metabolism and fascial hydration, which affect tissue glide and mobility
Why this matters in rehab:
Patients with insufficient estrogen often present with increased pain sensitivity, slower tissue healing, and reduced tolerance for load progression.
Optimized physiology supports more predictable gains from spinal stabilization, hip-hinge retraining, and eccentric tendon protocols.
Better vascular and neural function improves the efficacy of neurodynamic mobilizations and sensory-motor integration.
Receptor Pharmacology: Precision Matters for Clinical Outcomes
Receptors are not passive docks; they are signal transducers. Progesterone binds the progesterone receptor, androgens bind androgen receptors, and estrogens bind ERα/ERβ. Synthetic molecules (progestins) may occupy receptors without delivering the intended genomic and non-genomic actions, a phenomenon that can block beneficial signaling. From a rehabilitation perspective:
If beneficial signaling is blocked, we may see blunted neuroplastic changes despite effective exercise programming.
An accurate understanding of receptor biology helps anticipate tissue response and time rehabilitation phases more effectively.
In practice at El Paso Back Clinic:
We keep hormones and medications in the background, emphasizing manual therapy, mobility restoration, and load management.
When medical collaboration is needed, we use it to complement—not replace—restorative musculoskeletal care.
Bone Health, Load Tolerance, and Progressive Conditioning
Bone is a living, mechanosensitive tissue. All three sex hormones—estrogen, progesterone, and testosterone—have receptors on osteoblasts, osteoclasts, and osteocytes. Estrogen supports bone mineral density and reduces excessive resorption; testosterone and progesterone also contribute to bone integrity. Clinically, this is why:
Progressive weight-bearing and impact training (when appropriate) stimulates osteogenesis through mechanotransduction.
Spinal alignment and hip control distribute forces safely, avoiding stress concentrations.
Eccentric loading of tendons helps collagen alignment, improving functional stability around load-bearing joints.
Treatment reasoning:
We sequence care: mobility and pain modulation first, then neuromuscular control, then graded strength, then task-specific power and endurance.
For osteopenic patients, we use low- to moderate-impact drills with careful progression, augmented by balance training to reduce fall risk.
Breathing mechanics and rib-pelvis coordination enhance axial load management through the thoracolumbar fascia.
Brain Health, Pain Processing, and Neurodynamic Rehabilitation
Estrogen and testosterone influence apoptosis, beta-amyloid deposition, and synaptic signaling. Estrogen exhibits neuroprotective and immunomodulatory effects, stabilizing microglial and astrocytic behavior. In clinical practice:
Central sensitization is addressed with layered strategies: education, graded exposure, sensorimotor retraining, breath-led parasympathetic activation, and movement variability.
Neurodynamic tests and mobilizations (median, ulnar, radial, and sciatic biasing) are more effective when systemic inflammation is controlled.
Cognitive clarity and mood stability improve adherence and motor learning; sleep quality amplifies consolidation of motor patterns.
What I see in the clinic:
Patients with more stable physiology (including balanced estrogen) progress faster in lumbar stabilization and cervical deep flexor training.
Headache and neck pain with neurovascular components respond better to upper cervical mobilization, rib mobility, and scalene/SCM load management when endothelial and autonomic tone are optimized.
Cardiovascular Protection, Endothelial Function, and Exercise Capacity
Vascular health influences how well tissues are perfused during rehabilitation. Estrogen supports nitric oxide signaling, reduces vascular inflammation, and slows the progression of atherosclerosis in appropriate contexts. Clinical application:
Interval walking, tempo cycling, or rower intervals increase endothelial nitric oxide bioavailability; this improves recovery between strength sets and accelerates tissue oxygenation.
Calf pump drills and thoracic expansion work aid venous return, complementing manual therapy for patients with leg heaviness or postural orthostatic issues.
Better endothelial function correlates with improved VO2 kinetics and perceived exertion; patients sustain longer, more productive sessions.
Gut-Brain Axis, Inflammation, and Tissue Recovery
The gut metabolizes estrogen and communicates via immune and neural pathways. Dysbiosis and barrier dysfunction can amplify systemic inflammation and pain. In PT-chiropractic care:
We encourage anti-inflammatory nutrition, hydration, movement, healthy snacks, and stress modulation to support the microbiome.
Improved gut-brain signaling often leads to reduced hyperalgesia and faster normalization of myofascial tone.
Clinical protocols I favor:
Low-friction gliding techniques and pin-and-stretch when fascial adhesions are prominent
Segmental stabilization with diaphragmatic breathing to reduce sympathetic drive
Chiropractic and Physical Therapy Integration: Practical Pathways
I design integrated plans that prioritize spinal mechanics, functional strength, and neuromuscular timing, reserving medical adjustments to support—not lead—the process.
Core elements we use:
Manual therapy:
High-velocity, low-amplitude (HVLA) adjustments for segmental dysfunction when indicated
Joint mobilizations (grades I–IV) to restore physiological motion
Soft tissue release for paraspinals, deep hip rotators, and thoracic extensors
Spinal stabilization sequences: dead bug progressions, bird dog with anti-rotation focus, short-lever side planks
Hip hinge and split-stance patterns to load glutes and protect the lumbar spine
Neurodynamics:
Sliders and tensioners are applied judiciously with symptom-guided dosing
Cervicobrachial interface mobilization with scapular control
Mobility:
Thoracic extension and rotation drills to offload lumbar segments
Hip external/internal rotation restoration to normalize gait mechanics
Conditioning:
Stationary cycling, incline walking, or sled pushes for controlled metabolic load
Eccentric calf and hamstring protocols for tendon resiliency
Why these techniques:
HVLA can reset aberrant segmental mechanics, enabling more efficient firing of stabilizers.
Joint mobilizations and soft tissue work reduce nociceptive input, clearing the way for motor learning.
Neurodynamic work normalizes nerve glide, often reducing distal symptoms and improving strength expression.
Conditioning ensures that tissues tolerate the demands of life; mitochondria and capillaries adapt to support performance and pain resilience.
Clinical Observations at El Paso Back Clinic
Across thousands of patient encounters, I consistently observe:
When we stabilize the spine and retrain movement, symptoms improve faster if systemic inflammation is reduced.
Women entering perimenopause often report new-onset visceral fat and diffuse pain; restoring movement patterns and engaging progressive strength rapidly improves function, while physiology support fine-tunes consistency.
Post-stroke and concussion patients benefit from breath-paced mobility, vestibular-visual integration, and gentle cervical/thoracic mobilizations; progress accelerates when sleep and autonomic balance improve.
Men with persistent low back pain frequently show poor hip internal rotation and gluteal inhibition; targeted hip work plus spinal mechanics yields durable change.
Pain Modulation: Descending Inhibition and Predictable Progressions
Estrogen has documented effects on pain circuitry, including regulation of descending inhibitory pathways. Rather than discussing hormones directly with every patient, we operationalize the concept:
Educate on pain neurobiology to reduce fear
Use graded exposure with tolerable, repeatable tasks
Pair manual therapy with precise motor tasks immediately afterward to lock in pattern changes
Reinforce daily rituals: short mobility blocks, walking intervals, breath cues
This sequence exploits neuroplastic windows:
Manual therapy reduces nociception
Movement patterns encode efficient muscle synergies
Repetition consolidates synaptic changes
Sleep and recovery protect gains
Alzheimer’s, Cognition, and Rehabilitation Adherence
Cognition influences adherence, safety, and learning. The research base links balanced estrogen physiology to improved executive function in specific populations. Clinically, we:
Simplify instructions and use chunked, repeatable cues
Add dual-task drills at the right time (e.g., marching with head turns)
Use a metronome or breath cues to enhance rhythm and memory encoding
Gate progression by consistent performance rather than calendar dates
Cardiometabolic Integration: Weight, Visceral Fat, and Movement
Visceral adiposity can reduce tissue perfusion and amplify inflammatory signaling. Movement is medicine:
Prioritize daily steps and posture resets
Add glute and midline strength to redistribute loads from passive structures
Use intervals to improve insulin sensitivity and autonomic balance
Track waist circumference, step count, and perceived exertion; these map to functional outcomes in spine care
Individualized Care Over Rigid Rules
Consensus statements have evolved toward individualized decision-making for therapy type, dose, route, and duration in specialized contexts. In our rehab-first model:
We do not rely on blanket discontinuation or time-limited protocols
We reassess regularly, adjusting exercise intensity, manual therapy frequency, and home programming
Medical collaboration is case-based, primarily for safety and systemic support, while the backbone remains movement, alignment, and neuro-muscular conditioning
Safety, Nuance, and Clinical Reasoning
Safety is anchored in thorough assessment:
Screen for red flags, neurological deficits, vascular risk, and bone integrity
Tailor mobilization and manipulation intensity to tissue status and patient response
Advance loads using “stable form, stable symptoms” criteria
In complex cases (e.g., cancer history, stroke), coordinate with medical teams and emphasize gentle, progressive care with clear outcome metrics
What Patients Can Expect at El Paso Back Clinic
A detailed movement and neurological assessment
A clear plan anchored in functional goals
Manual therapy to unlock mobility
Progressive strength and neurocontrol to protect gains
Education and lifestyle guidance to support inflammation control and recovery
Transparent outcome tracking and friendly accountability
Step accrual goals matched to baseline (e.g., +1,000 steps from current baseline)
Foundational strength: hinges, rows, carries, and anti-rotation presses
Sleep routine and light exposure to anchor the circadian rhythm
Hydration and protein targets to support tissue repair
Closing Perspective: Teach People How Not To Be Sick
The best testimonial is a patient who no longer needs constant care. When physiology supports tissue health and when movement patterns are robust, people return to life—lifting kids, walking hills, and working without pain. My role is to guide, adjust, and progress your plan thoughtfully. Evidence keeps us honest; clinical observation keeps us human. At El Paso Back Clinic, chiropractic precision and physical therapy science meet to build durable outcomes.
In-text citations:
Estrogen and cognition, neuroprotection, and immunomodulation (e.g., Brinton, 2009; Pike et al., 2022).
Bone health and sex hormone receptors; osteogenesis under load (e.g., Khosla, 2010; Manolagas, 2010).
Cardiovascular endothelial function with estrogen; nitric oxide signaling (e.g., Mendelsohn & Karas, 2005).
Pain modulation and estrogen’s role in CNS injury responses (e.g., Vegeto et al., 2003).
Clinical practice position statements emphasizing individualized approaches (e.g., The North American Menopause Society, 2017).
Proactive Spine and Joint Care: Evidence-Based Chiropractic, Physical Therapy, and Integrative Rehabilitation for Better Patient Outcomes
Abstract
This post explores the historical evolution of modern medicine, tracing its path from protocol-driven practices in the 19th and 20th centuries to the rise of the pharmaceutical industry and the current “pill-for-an-ill” model. I will discuss the widespread use of medications like statins and the emerging evidence suggesting potential downsides, particularly regarding brain health and immune function. As a Doctor of Chiropractic and Advanced Practice Registered Nurse, I have observed the limitations of a purely reactive, symptom-based system. This article advocates for a fundamental shift towards proactive, personalized healthcare that integrates evidence-based chiropractic care, physical therapy, and nutritional science. We will delve into why a “one-size-fits-all” approach is failing our patients and how a holistic, patient-centered model that addresses the root cause of dysfunction—rather than just masking symptoms—is essential for restoring true health and vitality. We’ll examine the importance of critical thinking, medical freedom, and the powerful role of integrative therapies in transforming patient outcomes and reshaping the future of medicine.
As a healthcare professional with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), I’ve had a unique vantage point from which to observe the landscape of modern health. My clinical experience at the El Paso Back Clinic has reinforced a core belief: to truly heal, we must look beyond symptoms and address the whole person. This post presents the latest findings from leading researchers and my own clinical observations to advocate for a more integrated, proactive approach to your health.
The Rise of the Pill: A Shift in Medical Thinking
The trajectory of modern medicine has been fascinating and, in some ways, troubling. The early 1900s saw science and industry reshape healthcare, leading to incredible advancements. However, this era also paved the way for a business-centric model. By the 1980s, a significant shift occurred, with a prioritization of standardized protocols that aligned perfectly with the rise of Big Pharma.
A landmark moment came in 1987 with the introduction of the first statin medication. This event solidified a new paradigm in patient care: conduct a blood test, identify a number outside the “normal” range, and prescribe a pill to correct it. This “number-and-a-pill” approach became the cornerstone of chronic disease management.
Let’s look at the most prescribed medications in the United States today. Data projections for 2025 are staggering:
Statins: Over 200 million patients.
Metformin: 150 million patients.
Ibuprofen: 56 million patients.
These numbers reveal a system heavily reliant on pharmaceutical intervention. While these drugs can be life-saving in acute situations, their long-term use for chronic conditions requires careful consideration, particularly in light of the physiological consequences.
The Statin Dilemma: Unintended Consequences for Brain and Body
For decades, the prevailing medical wisdom has been to lower cholesterol levels aggressively to prevent heart disease. While the intention is beneficial, we must ask critical questions about the downstream effects of this strategy.
What is cholesterol? It’s not an evil substance to be eradicated. In fact, cholesterol is a vital component of every cell membrane in your body. It is particularly crucial for the brain. Your brain’s volume is largely composed of cholesterol, which is essential for forming neuronal connections and ensuring proper neurological function.
So, when we systemically suppress cholesterol levels with statins, what are the potential long-term effects? Emerging research and clinical observations suggest we may be inadvertently contributing to another epidemic: Alzheimer’s disease and dementia. What was once considered a rare disease is now frighteningly common. A growing body of evidence indicates a correlation between chronically low cholesterol levels and an increased risk of cognitive decline (Du et al., 2018). We are, in essence, potentially shrinking our patients’ brains in the pursuit of a specific number on a lab report.
Furthermore, a study from February 2025 revealed another critical role of cholesterol: it fuels dendritic cells, which are key players in the immune system. These cells are activated by tumors and help mount a stronger immune response to cancer (Ringel et al., 2023). By reflexively crushing cholesterol, are we also dampening our body’s natural ability to fight disease? This is a question we must have the courage to ask.
From a chiropractic and physical therapy perspective, I see patients whose primary complaints of musculoskeletal pain, weakness, and fatigue are often intertwined with systemic issues. It is not uncommon for patients on long-term statin therapy to report muscle aches and weakness, which can significantly hinder their progress with physical rehabilitation and chiropractic adjustments. Addressing the whole physiological picture is paramount.
The Current System: Reactive, Impersonal, and Ineffective
My experience with the conventional medical system, even as a patient, has often felt cold and impersonal. The typical waiting room experience—the sterile environment, the focus on insurance cards and numbers—reflects a larger problem. The system is designed for efficient processing of people, not for fostering healing relationships. This is the “here’s your pill, see you in six months” model of sick care.
This reactive approach was further entrenched in 2010 with the Affordable Care Act, which brought big insurance and big government into an even closer alliance with big pharma. The result has been a multi-trillion-dollar industry focused on medical research and pharmaceutical sales, while reimbursement for practitioners—the ones providing hands-on care—continues to shrink. The global pharmaceutical industry’s net profit in 2024 was estimated at a staggering $1.7 trillion.
Despite this massive expenditure, we are sicker than ever. We spend nearly $4.9 trillion annually on healthcare in the U.S., yet chronic diseases like diabetes, heart disease, and autoimmune conditions are rampant. The people I see every day in my clinic—our friends, family, and neighbors—are not getting well. They are being managed, their symptoms band-aided, but the underlying causes of their diseases are rarely addressed.
A New Path Forward: Proactive, Personalized Healthcare
The good news is that patients and practitioners are starting to question this broken model. There is a growing demand for something different, something better. The core principle that medicine has forgotten is that choice isn’t optional; it’s everything.
A “one-size-fits-all” approach to health makes no logical sense. Each of us is genetically and biochemically unique. We have different histories, lifestyles, and environmental exposures. How can we possibly expect the same protocol, the same medication, and the same dosage to work for everyone? At my clinic, this is a foundational principle. Treatment plans for chronic low back pain or post-surgical recovery are always tailored to each individual’s specific needs, functional capacity, and health goals.
Today, we stand at a crossroads. We can continue down the path of reactive sick care, or we can choose to become proactive champions of true healthcare. This means shifting our mindset:
We go to the doctor to stay well, not just because we are sick.
We treat patients, not lab reports or imaging studies.
We dig into the root cause of disease rather than just silencing symptoms.
The Return of Curiosity and Critical Thinking
To make this shift, we must revive curiosity and critical thinking in medicine. It takes character to admit that what we’ve been doing may not be the best way. It’s easy to defend the status quo, but it takes courage to step back, look at the evidence, and say, “We can do better.”
I am not anti-allopathic medicine. We have the most remarkable surgical and emergency care in the world. The problem isn’t the tools; it’s the over-reliance on a single tool—the prescription pad—for every problem. The cycle of “a pill for this, and another pill for the side effect of that” has led us astray.
We must remember that we are treating human beings, not pieces of paper. How often does a practitioner stare at a lab report while the patient sits before them, unheard? True healing begins when we put down the paper and engage with the person. In my practice, the patient’s story—their subjective experience of pain, their daily struggles, their goals—is just as important as the objective findings from a physical exam or an X-ray. It’s in that conversation that we uncover the clues to the root cause of their suffering.
Nutrition and Lifestyle: The Missing Pillars of Health
For years, integrative practitioners have championed the role of nutrition in health, often to the skepticism of the mainstream. Now, the tide is turning. Major institutions are finally acknowledging that advising patients on nutrition fosters a more holistic and comprehensive approach to health. Addressing a patient’s diet can dramatically increase their response to other therapies, including chiropractic care and physical therapy. Chronic inflammation, often driven by a poor diet, can stall healing and perpetuate pain cycles. By incorporating nutritional guidance, we can reduce systemic inflammation, providing a better physiological environment for tissues to heal and respond to manual therapies.
Your cells don’t have a political affiliation. They respond to the information they are given—whether it comes from food, movement, or stress. We must start treating food as the powerful medicine it is. The change may be slow, but the science is clear. Following the evidence on nutrition will profoundly shift our patients’ health over the next five to ten years.
Similarly, we are seeing a re-evaluation of long-held beliefs, such as the idea that estrogen causes cancer. New evidence has led the FDA to reconsider its stance, recognizing that bioidentical hormone therapy may actually protect the heart, brain, and bones. While our clinic’s focus is on musculoskeletal health, we recognize that hormonal balance plays a crucial role in tissue repair, inflammation, and overall well-being. Acknowledging this interplay is part of a truly integrative approach.
Breaking Free from Cognitive Inertia
One of the major obstacles to progress is a psychological phenomenon known as cognitive inertia. This is the human tendency to stick with familiar mental models and resist information that challenges our existing beliefs—a form of confirmation bias.
Albert Einstein famously said, “We cannot solve our problems with the same thinking we used when we created them.” We must get out of our own way. We have to be willing to challenge our biases and embrace a new way of thinking that prioritizes the individual.
This means transitioning from treating the masses to personalizing medicine. We must remember the humanity of our patients. They are mothers, fathers, teachers, and grandparents. They are the fabric of our community. When they don’t feel well, they cannot fully participate in their own lives. Helping them regain their health, vitality, and life itself is the true calling that brought most of us to medicine in the first place.
The Future of Medicine Begins Now
On March 27, 2026, we embark on a new journey. This is the day we commit to a different path. History remembers the practitioners who didn’t just follow the system, but transformed it. Today, that responsibility belongs to us. We have the option to either remain within the confines of an outdated model or to initiate a change.
Let’s make this our finest hour. Let’s:
Treat patients, not cases.
Provide proactive healthcare, not reactive sick care.
Be integrative, not just allopathic.
Become true wellness and healthcare providers.
The future of medicine is about restoring health freedom—your freedom as a patient to choose the care that is right for you, and our freedom as practitioners to provide it. It’s about empowering you with the knowledge and tools to take control of your health. It’s about digging deeper, treating smarter, and never forgetting the person behind the pain.
References
Du, F., Yu, Q., Li, X., & Cao, Y. (2018). The role of cholesterol in the pathogenesis of Alzheimer’s disease. Journal of Alzheimer’s Disease, 63(4), 1223–1235. https://doi.org/10.3233/JAD-180026
Ringel, A. E., Drijvers, J. M., Baker, G. J., Cato, L., Sir-Dane, K. A., Gyonfi, A., & Haigis, M. C. (2023). Cholesterol biosynthesis inhibition reprograms the tumor immune microenvironment to allow for effective combination immunotherapy. Science Advances, 9(33), eadg7537. https://doi.org/10.1126/sciadv.adg7537
IFM's Find A Practitioner tool is the largest referral network in Functional Medicine, created to help patients locate Functional Medicine practitioners anywhere in the world. IFM Certified Practitioners are listed first in the search results, given their extensive education in Functional Medicine
